Thus, we demonstrate cyclosporine treatment of human hepatoma cells to significantly reduce DNA-binding of HNF4α to AGT and AGTR1 at gene specific promoters to cause impaired gene expression. The gene discussed is HNF4A; the disease is hepatocellular carcinoma.